Christopher L. Towne,Claire Discenza,Sean McCormack
申请号：
US16296063
公开号：
US20190275169A1
申请日:
2019.03.07
申请国别(地区):
US
年份:
2019
代理人:
摘要：
One embodiment is directed to a method for treating the nervous system of a patient, comprising: determining a desired nervous system functional modulation to be facilitated by optogenetic intervention； selecting targeted neuroanatomy for achieving the desired functional outcome with optogenetic intervention； and delivering an effective amount of polynucleotide comprising a light-responsive opsin protein which is expressed in neurons of the targeted neuroanatomy, and delivering an effective amount of immunosuppressant.
